Care
The company's Precision DL speeds up screening time, enhances the image quality of PET/CT scans and improves small lesion detection.
HIMSS23
Tim O'Connell, CEO and founder of Emtelligent, talks about Emtelligent's NLP software, which is specially designed to understand medical English, and how it can assist drug companies with finding clinical trial cohorts from patient records.
The California-based company will use the funds to expand its oncology and surgical care-focused offerings.
HIMSS23
Dr. Colin Banas, chief medical officer at DrFirst, discusses how his company uses AI to automate tasks such as processing prescription refills, which prevents medication errors and reduces clinicians' administrative burden.
Julien Pham, founder and managing partner of Third Culture Capital, discusses 3CC's quest to invest in founders from various backgrounds and help the companies prosper.
HIMSS23
Cleveland Clinic’s chief research information officer, Lara Jehi, and Craig Martin, IT product director for population health, discuss how digital tools help clinicians maintain continuity of care for patients with complex health issues.
Dr. Jay Bhatt, managing director at Deloitte, warns that without high-quality algorithms technology has the potential to increase health inequities and drive mistrust.
HIMSS23
Robert Stillman, director of clinical and research informatics at the Ohio State University Wexner Medical Center, discusses the challenges of chairing the Global Health Conference Education Committee for HIMSS23.
HIMSS23
Grace Cordovano, founder of Enlightening Results, describes her work with Unblock Health, a digital platform that streamlines the process of requesting medical records and corrections to medical records for patients.
The Utah-based company will utilize Microsoft's AI technology to expand its machine learning speech models and accelerate AI-enabled speech analysis technology.